Fidelity Value Fund
FDVLX
NASDAQ- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 245 Summer Street Boston MA United States of America 02210
- IPO Date
- Jan 2, 1980
- CIK
- 0000275309
- Website
- fundresearch.fidelity.com
- Similar Companies
- Business
- Fidelity Value Fund (FDVLX) is an actively managed open-end mutual fund that seeks capital appreciation by investing primarily in equity securities of companies believed to possess valuable fixed assets or to be undervalued relative to factors such as assets, earnings, or growth potential, often referred to as value stocks; the fund normally invests at least 80% of its assets in these securities, which may include common stocks, preferred stocks, convertible securities, and other equity-related instruments across various market capitalizations, with a focus on U.S. companies but potential exposure to foreign issuers. It offers share classes including no-load retail shares with a net expense ratio of 0.81%, daily liquidity, and availability to individual and institutional investors through platforms in the United States. The fund, part of the Fidelity Investments family headquartered in Boston, Massachusetts, was originally launched in December 1978 under Fidelity Capital Trust and manages total net assets of approximately $8.13 billion as of late 2025, primarily benchmarked against the Russell 3000 Value Index. Portfolio management is led by Matthew Friedman since May 2010, alongside co-managers Laurie Mundt and Shadman Riaz since June 2010, emphasizing bottom-up stock selection within sectors exhibiting undervaluation or attractive asset bases. Recent developments include sustained strong performance with a 5-year annualized return of 16.98% as of September 2025, positioning it in the top third of its Large Value category peers, alongside quarterly portfolio manager updates as of April 30, 2025, highlighting strategic adjustments amid market volatility; no major acquisitions, mergers, or structural changes have been reported in the last 1-2 years, though the fund maintains active portfolio turnover and position adjustments such as reduced stakes in select holdings like Tenet Healthcare and Harley-Davidson in late 2024. Operations remain centered in the U.S. with global equity exposure opportunities for diversification.